US 11883431
T-cells modified to overexpress PHF19
granted A61KA61K40/11A61K40/4273
Quick answer
US patent 11883431 (T-cells modified to overexpress PHF19) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K40/11, A61K40/4273, A61P, A61P31/12